How we achieve high level corporate partnerships with companies - - PowerPoint PPT Presentation

how we achieve high level corporate partnerships with
SMART_READER_LITE
LIVE PREVIEW

How we achieve high level corporate partnerships with companies - - PowerPoint PPT Presentation

How we achieve high level corporate partnerships with companies given the health advocacy and promotion priorities of the UICC and some of the challenges that arise in a global context. World Cancer Declaration 3 Key Questions Can


slide-1
SLIDE 1

“How we achieve high level corporate partnerships with companies given the health advocacy and promotion priorities of the UICC and some

  • f the challenges that arise in a

global context.”

slide-2
SLIDE 2

World Cancer Declaration

slide-3
SLIDE 3

3 Key Questions

  • Can we deliver the World Cancer

Declaration targets without engaging the private sector?

  • Which corporate players should we work

with and partner?

  • Conflict of interest in Global Advocacy?
slide-4
SLIDE 4

Essential to our future

slide-5
SLIDE 5

Not essential to our future

slide-6
SLIDE 6

Corporate impact

Nearly 70% of the working population is employed by the private sector

slide-7
SLIDE 7
slide-8
SLIDE 8
slide-9
SLIDE 9

Key Questions

  • Can we deliver the World Cancer

Declaration targets without engaging the private sector?

  • Which corporate players should we work

with and partner?

  • Conflict of interest in Global Advocacy?
slide-10
SLIDE 10

An extreme view

  • An NGO should not associate itself in any way

with a private sector company because there is an inherent conflict of interest.

  • Taking restricted or unrestricted funding is

irrelevant

  • An NGO which takes private sector funding is a

“BINGO” (Business Interest NGO) and their view will be affected by the relationship

  • An NGO which does not is a “PINGO” (Public

Interest NGO)

slide-11
SLIDE 11

Ranges of possibilities

  • Within the UICC membership we have a

wide range of NGOs which do or do not have relationships with the private sector

  • Some have relationships with sub-brands
  • f large corporate entities, but not the

main corporate.

  • Some have local or regional relationships

but not global relationships.

  • Restricted and unrestricted
slide-12
SLIDE 12

UICC enjoys positive partnerships with many organisations

Ecosoc status with the United Nations Formal Relations with WHO Partner with IAEA and IARC

UN AGENCIES

slide-13
SLIDE 13

UICC enjoys positive partnerships with many organisations

slide-14
SLIDE 14

It’s not simply black and white

Avoid ¡ Talk ¡ Partner ¡

slide-15
SLIDE 15

Partner Assessment Framework

Direct Impact on Cancer and NCDs CSR/Foundation Activity Workforce Wellness Approach Advocacy Activity Scale of Impact Appetite for Change Cause Nil Negative Hinders Local Negative Solve Active Effective Helps Global Positive Conflict High Low

Avoid ¡ Talk ¡ Partner ¡

Complementary Skills/Expertise/Assets Weak Strong

slide-16
SLIDE 16

Example 1: tobacco company

Direct Impact on Cancer and NCDs CSR/Foundation Activity Workforce Wellness Approach Advocacy Activity Scale of Impact Appetite for Change Cause Nil Negative Hinders Local Negative Solve Active Effective Helps Global Positive Conflict High Low

Avoid ¡ Talk ¡ Partner ¡

Complementary Skills/Expertise/Assets Weak Strong

slide-17
SLIDE 17
slide-18
SLIDE 18
slide-19
SLIDE 19
slide-20
SLIDE 20
slide-21
SLIDE 21
slide-22
SLIDE 22

Example 3: food and beverage

Direct Impact on Cancer and NCDs CSR/Foundation Activity Workforce Wellness Approach Advocacy Activity Scale of Impact Appetite for Change Cause Nil Negative Hinders Local Negative Solve Active Effective Helps Global Positive Conflict High Low

Avoid ¡ Talk ¡ Partner ¡

Complementary Skills/Expertise/Assets Weak Strong

slide-23
SLIDE 23

3 Key Questions

  • Can we solve the global cancer and NCD

challenge without engaging the private sector?

  • Which corporate players should we work

with and partner?

  • Conflict of interest in Global Advocacy?
slide-24
SLIDE 24

Global advocacy involves everyone.

  • Everyone is involved in global advocacy for health – UN, WHO,

governments, private sector, academia, civil society, individuals, you.

  • Alliances both formal and informal form on a regular basis linked to

a theme, an issue or in opposition to another view

  • Players can adopt several positions on the same issue (or change

position quickly for no apparent reason)

  • Strange alliances emerge and unexpected positions can be adopted

– sometimes linked to completely unrelated issues

  • There are few “pure” right/correct views, and compromise

(consensus) dominates thinking as a “good result”

  • Trading takes place
  • The words used are incredibly important
  • Many players are skilled diplomats and politicians – not enthusiastic

amateurs

  • There are many tourists and side shows
slide-25
SLIDE 25

It’s not simply black and white – advocay response

Avoid/ ¡ counter ¡ Talk/ ¡ ¡ coerce ¡ Partner/ plan ¡

slide-26
SLIDE 26

Key things for success

  • Know what you want – Proposed Outcomes

Document from the NCD Alliance

  • Support your demands with evidence
  • Have a plan and the resource to execute the plan
  • Understand who can influence the outcome you

want (in the UN system, member states, individuals, other organisations)

  • Get to them professionally and effectively
  • Choose your partners/allies wisely, issue by issue
  • Counter the opposition
  • Stay the course
slide-27
SLIDE 27

Impact on partnerships

  • You don’t have to agree on everything
  • Transparency in the relationship is critical
  • A firewall on policy issues is critical
  • Use independent scientific evidence to

substantiate all positions you adopt

  • What’s the economic argument for action?

– Head, heart and pocket

slide-28
SLIDE 28

Measuring success

  • A UN High Level Meeting on NCDs
  • An increased understanding and awareness of

NCDs around the world – no longer the forgotten diseases

  • A global goal to reduce premature deaths throgh

NCDs by 25% by 2025

  • A commitment to agree 10 targets and many

indicators to measure progress, by the end of 2012

  • NCDs in the replacement MDGs in 2015